The Duration of Protection from Azithromycin Against Malaria, Acute Respiratory, Gastrointestinal, and Skin Infections When Given Alongside Seasonal Malaria Chemoprevention: Secondary Analyses of Data from a Clinical Trial in Houndé, Burkina Faso, and Bougouni, Mali

BACKGROUND: Mass drug administration (MDA) with azithromycin (AZ) is being considered as a strategy to promote child survival in sub-Saharan Africa, but the mechanism by which AZ reduces mortality is unclear. To better understand the nature and extent of protection provided by AZ, we explored the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Phiri, Mphatso Dennis, Cairns, Matthew, Zongo, Issaka, Nikiema, Frederic, Diarra, Modibo, Yerbanga, Rakiswendé Serge, Barry, Amadou, Tapily, Amadou, Coumare, Samba, Thera, Ismaila, Kuepfer, Irene, Milligan, Paul, Tinto, Halidou, Dicko, Alassane, Ouédraogo, Jean Bosco, Greenwood, Brian, Chandramohan, Daniel, Sagara, Issaka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492219/
https://www.ncbi.nlm.nih.gov/pubmed/33417683
http://dx.doi.org/10.1093/cid/ciaa1905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492219/
https://www.ncbi.nlm.nih.gov/pubmed/33417683
http://dx.doi.org/10.1093/cid/ciaa1905

Ejemplares similares